You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EZH2

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))

Not yet recruiting
  • Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Tazverik (Tazemetostat)
  • (no location specified)
Oct 6, 2023

Non Small Cell Lung Cancer Trial in West Los Angeles (Tazemetostat)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • West Los Angeles, California
    VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Jul 21, 2022

DNA Methylation and Histone Modification in H. Pylori Associated

Recruiting
  • Gastric Carcinoma
  • Immunohistochemical staining for DNMT1 and EZH2
  • Assiut, Egypt
    Assiut University
Mar 31, 2023

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

Completed
Has Results
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Nagoya, Aichi, Japan
  • +27 more
Nov 18, 2022

Relapsed/Refractory Follicular Lymphoma With EZH2 Trial in Shanghai (Tazemetostat)

Not yet recruiting
  • Relapsed/Refractory Follicular Lymphoma With EZH2
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Jul 20, 2022

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

Advanced Follicular Lymphoma:Translational Study From FIL_FOLL12

Not yet recruiting
  • Follicular Lymphoma
  • EZH2 mutations/CNAs by droplet digital PCR (ddPCR)
  • EZH2-derived gene expression signature by RNA-Seq
  • Alessandria, Italy
  • +25 more
Apr 4, 2023

B-Cell Lymphoma Trial in United States (CPI-1205)

Completed
  • B-Cell Lymphoma
  • Lafayette, Indiana
  • +5 more
May 16, 2022

Breast Cancer Trial in Houston (Trastuzumab deruxtecan, Valemetostat)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 14, 2022

Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or

Recruiting
  • Triple-negative Breast Cancer
  • Pyrotinib with Capecitabine
  • +6 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 8, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2) Trial in Worldwide

Completed
  • B-cell Lymphomas (Phase 1)
  • +5 more
  • Birmingham, Alabama
  • +51 more
Dec 8, 2021

Mesothelioma, BAP1 Loss of Function Trial in France, United Kingdom, United States (Tazemetostat)

Completed
Has Results
  • Mesothelioma
  • BAP1 Loss of Function
  • Los Angeles, California
  • +15 more
Mar 16, 2021

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Los Angeles, California
  • +34 more
Dec 23, 2021

Solid Tumor, Lymphoma Trial in Beijing (SHR2554+SHR1701, SHR1701)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Sep 22, 2020

Acute Myeloid Leukemia Trial (Cytogenetic analysis (FISH) for EZH2 gene deletion. -Real time PCR for PHF 19 gene expression.)

Unknown status
  • Acute Myeloid Leukemia
  • Cytogenetic analysis (FISH) for EZH2 gene deletion. -Real time PCR for PHF 19 gene expression.
  • (no location specified)
Jan 1, 2020

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Follicular Lymphoma Trial in United States (Tazemetostat, Rituximab)

Recruiting
  • Follicular Lymphoma
  • Birmingham, Alabama
  • +19 more
Mar 29, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023

Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • +5 more
  • (no location specified)
Dec 2, 2022

Relapsed Adult AML Trial in Germany (Venetoclax Oral Tablet)

Recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Venetoclax Oral Tablet
  • Augsburg, Germany
  • +11 more
Jan 11, 2023

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023